Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides: comment

Citation

Flierl, U, Nero, T, Lim, B et al. 2018, 'Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides: comment', Journal of Thrombosis and Haemostasis, vol. 16, no. 1, pp. 181-185.

Year

2018

Field of Research

  • Receptors And Membrane Biology

Updated:  20 April 2024 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers